Global Scans · Brain Technologies · Weekly Summary

• [New] The world's first-in-human clinical trial using invasive intelligent brain devices-devices that predict specific neuronal events directly to the implanted person - has been completed with significant success. PubMed Central (PMC)
• [New] Deep Brain Stimulation Systems is anticipated to account for 38.7% of the product segment in 2026, while Neurological Disorders is expected to remain the leading application with around 42.5% share. FactMr
• [New] A best-selling brain supplement on Amazon could help. New York Post
• Musk stated that starting in 2026, Neuralink will commence mass production of brain implants, with a complete move to automated surgery for each implantation. TechEBlog
• By 2026, non-invasive Brain-Computer Interfaces (BCI) like Neural Dust and optical interfaces will redefine human-machine symbiosis, moving beyond simple commands to seamless neuro-digital integration. Emre Arslan
• Neuralink Targets Automated, High-Volume Brain-Computer Interface Production in 2026: Reuters reports Elon Musk said Neuralink will begin high-volume production of its brain-computer interface (BCI) devices in 2026 and aims to shift to an entirely automated surgical procedure. Scientific Inquirer
• With data centers projected to consume 3% of global electricity by 2030 due to conventional AI workloads, neuromorphic technology offers a sustainable pathway forward. Yahoo Finance
• The most persuasive outlook for 2026 is that neuromorphic compute will complement existing AI accelerators-delivering measurable advantages in energy-constrained, latency-sensitive environments while software maturity and ecosystem alignment catch up to hardware promise. Stanford Tech Review
• Emerging research in neuromorphic computing, advanced robotics integration, and decentralized identity management suggests that the next decade will redefine digital infrastructure further. Abbacus Technologies Pvt Ltd
• Intel has framed Loihi 2 as part of a broader ecosystem aimed at enabling neuromorphic research communities and collaborations to push practical boundaries, including thousands of neurons and millions of synapses per chip, and the potential to tile multiple chips for larger-scale experiments. Stanford Tech Review
• Mayo Clinic presentations will highlight advances in tumour biology, outcomes and risk prediction, as well as new treatment strategies and practice-changing studies in breast, colorectal, brain and prostate cancers. EurekAlert!
• Other options such as intracortical interfaces might require surgically implanting microelectrodes directly into a patient's brain cortex, such as the chips created by neurotechnology start-up Neuralink, founded by entrepreneur Elon Musk. ST
• Looking toward 2027, the boundary between neuromorphic and other frontier technologies is beginning to blur. IT
• SBMT 2026 will highlight revolutionary advances in brain imaging and neurotechnology. Society for Brain Mapping and Therapeutics
• The EU AI Act, which classifies brain-computer interfaces as high-risk AI systems, imposes stringent transparency and safety requirements that will shape how neurotechnology is developed and deployed across Europe. Tech for Impact Summit

Last updated: 24 May 2026